Research groups
Timothy Fredsgaard-Jones
Clinician
Clinical Research Fellow
I am a clinical research fellow working on tuberculosis vaccine platforms in Professor McShane's Group. I am an Infectious Diseases/GIM Specialist Registrar and NIHR Academic Clinical Fellow working in the Thames Deanery. I have a particular interest in Tuberculosis and Tropical Medicine, and have completed the DTMH and an MSc at the London School of Hygiene and Tropical Medicine.
I completed my medical training at the University of Cambridge and University College London, and have worked as a doctor in London, Glasgow and Oxford. I have conducted research in Tuberculosis, HIV, COVID-19 and enteral parasites both in the UK and Malawi.
In the McShane group I work on the design and clinical care of experimental medical BCG Challenge trials. While working here I have also been completing a Certificate of Health Research at the University of Oxford department of Continuing Education.
Recent publications
-
An assessment of the downstream implications of blood culture collection and transit
Journal article
Davies PJB. et al, (2023), European Journal of Clinical Microbiology & Infectious Diseases
-
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
Abani O. et al, (2023), The Lancet, 401, 1499 - 1507
-
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Journal article
Abani O. et al, (2022), The Lancet, 400, 359 - 368
-
Alcohol, smoking, recreational drug use and association with virological outcomes among people living with HIV: cross‐sectional and longitudinal analyses
Journal article
Jones TPW. et al, (2022), HIV Medicine, 23, 209 - 226
-
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
Abani O. et al, (2022), The Lancet, 399, 665 - 676